Chitosan/poly-γ-glutamic acid crosslinked hydrogels: Characterization and application as bio-glues.

Ecofriendly hydrogels were prepared using chitosan (CH, 285 kDa) and two fractions of low molecular weight microbial poly-γ-glutamic acid (γ-PGA) (R1 and R2 of 59 kDa and 20 kDa, respectively). The hydrogels were synthesized through sustainable physical blending, employing three CH/γ-PGA mass ratios (1/9, 2/8, and 3/7), resulting in the formation of physically crosslinked materials. The six resulting CH/R1 and CH/R2 hydrogels were physico-chemically characterized and the ones with the highest yields (CH/R1 and CH/R2 ratio of 3/7), analyzed for rheological and morphological properties, showed to act as bio-glues on wood and aluminum compared to commercial vinyl- (V1) and acetovinyl (V2) glues. Lap shear analyses of CH/R1 and CH/R2 blends exhibited adhesive strength on wood, as well as adhesive/cohesive failure like that of V1 and V2. Conversely, CH/R2 had higher adhesive strength and adhesive/cohesive failure on aluminum, while CH/R1 showed an adhesion strength with adhesive failure on the metal similar to that of V1 and V2. Scanning electron microscopy revealed the formation of strong physical bonds between the hydrogels and both substrates. Beyond their use as bio-adhesives, the unique properties of the resulting crosslinked materials make them potentially suitable for various applications in paint, coatings, heritage preservation, and medical sector.

Biomedical engineering of polysaccharide-based tissue adhesives: Recent advances and future direction.

Tissue adhesives have been widely used for preventing wound leaks, sever bleeding, as well as for enhancing drug delivery and biosensing. However, only a few among suggested platforms cover the circumstances required for high-adhesion strength and biocompatibility, without toxicity. Antibacterial properties, controllable degradation, encapsulation capacity, detectability by image-guided procedures and affordable price are also centered to on-demand tissue adhesives. Herein we overview the history of tissue adhesives, different types of polysaccharide-based tissue adhesives, their mechanism of gluing, and different applications of polysaccharide-based tissue adhesives. We also highlight the latest progresses in engineering of tissue adhesives followed by existing challenges in fabrication processes. We argue that future studies have to place focus on a holistic understanding of biomaterials and tissue surface properties, proper fabrication procedures, and development of magnetic and conductive responsive adhesives in order to bridge the huge gap between the present studies for clinical implementation.

Effect of the bio-inspired modification of low-cost membranes with TiO2:ZnO as microbial fuel cell membranes.

Microbial fuel cells (MFCs) are a novel technique for converting biodegradable materials into electricity. In this study, the efficiency of mixed crystal (TiO2:ZnO) as a membrane modifier of a low-cost, antifouling and self-cleaning cation exchange membrane for MFCs was studied. The modification was prepared using polydopamine (PDA) as the bio-inspired glue, followed by gravity deposition of a mixture of catalyst nanoparticles (TiO2:ZnO 0.03%, 1:1 ratio) as anti-biofouling agents. The effects of the membrane modification were evaluated in terms of power density, open circuit potential, coulombic efficiency, anti-biofouling properties and also color and COD removal efficiency. The results showed that the use of the PDA-modified membrane and a mixture of catalysts facilitated the transfer of cations released during the oxidation process in the anodic compartment of the MFC, which increased the power generation in the MFC by 2.5 times and 5.7 times the current compared to pristine and PDA pristine membranes, decreased the MFC operating cycle time from 5 to 3 days, doubled the lifetime of the membranes and demonstrated higher COD removal efficiency and color removal. Finally, SEM and AFM analysis showed that the modification significantly minimized surface fouling. The modified membranes in this study proved to be a potential alternative to the expensive membranes currently used in MFCs, furthermore, this modification could be an interesting alternative modification for other potential membranes for use in MFCs, due to the fact that the catalyst activation was only performed with visible light (artificial and solar), which could decrease operating costs.

Enhanced biocompatibility and adhesive properties of modified allyl 2-cyanoacrylate-based elastic bio-glues.

Despite cyanoacrylate's numerous advantages such as good cosmetic results and fast application for first aid, drawbacks such as brittleness and local tissue toxicity have limited their applicability. In this study, to improve both the biocompatibility and mechanical properties of cyanoacrylate, allyl 2-cyanoacrylate (AC) was pre-polymerized and mixed with poly(L-lactide-co-ɛ-caprolactone) (PLCL, 50:50) as biodegradable elastomer. For various properties of pre-polymerized AC (PAC)/PLCL mixtures, bond strength, elasticity of flexure test as bending recovery, cell viability, and in vivo test using rat were conducted and enhanced mechanical properties and biocompatibility were confirmed. Especially, optimal condition for pre-polymerization of AC was determined to 150°C for 40min through cytotoxicity test. Bond strength of PAC/PLCL mixture was decreased (over 10 times) with increasing of PLCL. On the other hand, biocompatibility and flexibility were improved than commercial bio-glue. Optimal PAC/PLCL composition (4g/20mg) was determined through these tests. Furthermore, harmful side effects and infection were not observed by in vivo wound healing test. These results indicate that PAC/PLCL materials can be used widely as advanced bio-glues in various fields.

Use of biological Glue (Bioglue®) in laparoscopic partial nephrectomy: a study in pigs

Introduction Partial nephrectomy is the standard of care for localized renal tumors. However, bleeding and warm ischemia time are still controversial when laparoscopic surgeries are carried out. Herein, we aim to compare the outcomes from laparoscopic partial nephrectomy with and without the use of biological glue with purified bovine albumin and glutaraldehyde (BioGlue®). Materials and Methods Twenty-four kidneys of 12 pigs were used in this study. A pre-determined lower pole segment was resected (3 cm x 1 cm) and one of two different hemostatic techniques was performed. In one kidney, hemostatic “U suture” (poliglecaprone 3.0) was performed and in the contra-lateral kidney, only the biological glue was applied. Data recorded was comprised of warm ischemia time (seconds) and estimated blood loss (mL) for each procedure. In cases of bleeding after glue administration, a complementary suture was done. Results Mean warm ischemia time was 492.9±113.1 (351-665) seconds and 746±185.3 (409-1125) seconds for biological glue and suture groups, respectively. There was a positive significant difference in terms of warm ischemia favoring the biological glue group over the suture group (p<0.001). Mean blood loss was 39.4 (0-115) mL for the biological glue group and 39.1 (5-120) mL for the suture group (p=0.62). Conclusion Biological glue is an important tool for laparoscopic partial nephrectomies. It is effective for hemostatic control in selected cases, and it can be used in combination with the traditional suture techniques. .

Biological glue application in repair of atrioventricular groove rupture: a case report.

Atrioventricular groove rupture is a rare, albeit mortal, complication following mitral valve surgery. Avoidance is the best strategy but it cannot fully prevent the occurrence of this complication. Several repair techniques have been described with varying success rates; however, the rarity of the complication precludes consensus about the safest technique. Here we report two cases of posterior atrioventricular groove rupture. Both cases were diagnosed immediately after the cessation of cardiopulmonary bypass. Repair was performed successfully with a technique involving the use of biological glue. The postoperative course was uneventful for both of them. Both cases are well with normally functioning mitral prostheses; one with a follow-up time of 5.5 years and the other 10 months. We believe that the glue provides additional hemostasis and support to the repaired area.